The top money raisers in biotech
The Top Line
Biotech Company's Fundraising Journey and Post-IPO Challenges
Explore the fundraising success of Metagenome, a gene editing company, through a $275 million series B round and an IPO, examining their market support test case status and decision-making post-public listing. Compare their diverse pipeline and business development challenges to established companies, discussing the impact of massive layoffs in the biotech industry.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
